|
Volumn 101, Issue 11, 2007, Pages 1061-1062
|
Animal models of human African trypanosomiasis-very useful or too far removed?
|
Author keywords
Animal models; Drug therapy; Drug toxicity; Human African trypanosomiasis; Sleeping sickness; Trypanosoma
|
Indexed keywords
ANTIPARASITIC AGENT;
BIOLOGICAL MARKER;
CYTOKINE;
DB 289;
GAMMA INTERFERON;
INTERLEUKIN 1;
INTERLEUKIN 10;
MELARSOPROL;
SUBSTANCE P;
TUMOR NECROSIS FACTOR ALPHA;
UNCLASSIFIED DRUG;
AFRICAN TRYPANOSOMIASIS;
BLOOD BRAIN BARRIER;
CIRCADIAN RHYTHM SLEEP DISORDER;
DISEASE COURSE;
DISEASE MODEL;
DRUG FATALITY;
DRUG RESEARCH;
DRUG TARGETING;
HUMAN;
INFLAMMATION;
KNOCKOUT MOUSE;
NONHUMAN;
PARASITE MIGRATION;
PATHOGENESIS;
PATHOPHYSIOLOGY;
REVIEW;
RISK BENEFIT ANALYSIS;
TRYPANOSOMA GAMBIENSE;
TRYPANOSOMA RHODESIENSE;
ANIMALS;
BLOOD-BRAIN BARRIER;
CENTRAL NERVOUS SYSTEM PROTOZOAL INFECTIONS;
DISEASE MODELS, ANIMAL;
HUMANS;
MICE;
PRIMATES;
RATS;
TREATMENT OUTCOME;
TRYPANOSOMA BRUCEI GAMBIENSE;
TRYPANOSOMIASIS, AFRICAN;
ANIMALIA;
MUS;
PRIMATES;
RATTUS;
TRYPANOSOMA;
|
EID: 34648843387
PISSN: 00359203
EISSN: None
Source Type: Journal
DOI: 10.1016/j.trstmh.2007.05.001 Document Type: Review |
Times cited : (10)
|
References (5)
|